These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17080390)

  • 1. Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection.
    Gavaldà L; Masuet C; Beltran J; Garcia M; Garcia D; Sirvent JM; Ramon JM
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1264-6. PubMed ID: 17080390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment.
    Wernitz MH; Keck S; Swidsinski S; Schulz S; Veit SK
    Clin Microbiol Infect; 2005 Jun; 11(6):466-71. PubMed ID: 15882196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?
    Papia G; Louie M; Tralla A; Johnson C; Collins V; Simor AE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):473-7. PubMed ID: 10432159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T; Oh PI; Simor AE
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
    Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
    Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for methicillin-resistant Staphylococcus aureus by hospitals.
    Harris R
    JAMA; 2008 Aug; 300(5):503; author reply 504-5. PubMed ID: 18677020
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs of an outbreak of meticillin-resistant Staphylococcus aureus.
    Kanerva M; Blom M; Tuominen U; Kolho E; Anttila VJ; Vaara M; Virolainen-Julkunen A; Lyytikäinen O
    J Hosp Infect; 2007 May; 66(1):22-8. PubMed ID: 17433492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital.
    Clancy M; Graepler A; Wilson M; Douglas I; Johnson J; Price CS
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1009-17. PubMed ID: 17006806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals.
    Resch A; Wilke M; Fink C
    Eur J Health Econ; 2009 Jul; 10(3):287-97. PubMed ID: 19015905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
    Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
    Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Murthy A; De Angelis G; Pittet D; Schrenzel J; Uckay I; Harbarth S
    Clin Microbiol Infect; 2010 Dec; 16(12):1747-53. PubMed ID: 20331684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?
    Rubinovitch B; Pittet D
    J Hosp Infect; 2001 Jan; 47(1):9-18. PubMed ID: 11161895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling transmission of methicillin-resistant Staphylococcus aureus among patients admitted to a hospital.
    Raboud J; Saskin R; Simor A; Loeb M; Green K; Low DE; McGeer A
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):607-15. PubMed ID: 16092740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin-resistant Staphylococcus aureus screening programs in US hospitals.
    Olchanski N; Mathews C; Fusfeld L; Jarvis W
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):250-7. PubMed ID: 21460510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, patient experience and cost impacts of performing active surveillance on known methicillin-resistant Staphylococcus aureus positive patients admitted to medical-surgical units.
    Goldsack JC; DeRitter C; Power M; Spencer A; Taylor CL; Kim SF; Kirk R; Drees M
    Am J Infect Control; 2014 Oct; 42(10):1039-43. PubMed ID: 25278390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.